SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-002768
Filing Date
2020-01-10
Accepted
2020-01-09 19:48:02
Documents
14
Period of Report
2020-01-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201717-1_8k.htm   iXBRL 8-K 26007
2 EXHIBIT 99.1 tm201717d1_ex99-1.htm EX-99.1 13989
3 GRAPHIC tm201717d1_ex99-1img001.jpg GRAPHIC 5211
  Complete submission text file 0001104659-20-002768.txt   224490

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvln-20200109.xsd EX-101.SCH 3186
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvln-20200109_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvln-20200109_pre.xml EX-101.PRE 22710
9 EXTRACTED XBRL INSTANCE DOCUMENT tm201717-1_8k_htm.xml XML 3519
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 20519235
SIC: 2834 Pharmaceutical Preparations